Brief: Fractyl Health Reports Positive 3-Month Reveal-1 Cohort Data
23/06/2025 12:49
June 23 (Reuters) - Fractyl Health Inc GUTS.O: FRACTYL HEALTH REPORTS POSITIVE 3-MONTH REVEAL-1 COHORT DATA SHOWING REVITA® SUSTAINED WEIGHT LOSS AFTER GLP-1 DISCONTINUATION, SUPPORTING ITS POTENTIAL AS A FIRST-IN-CLASS WEIGHT MAINTENANCE THERAPY FRACTYL HEALTH INC - 12 OF 13 PARTICIPANTS MAINTAINED OR LOST WEIGHT AT 3 MONTHS FRACTYL HEALTH INC - REVITA SHOWS EXCELLENT TOLERABILITY PROFILE COMPARED TO GLP-1 DRUGS FRACTYL HEALTH INC - RANDOMIZED MIDPOINT COHORT DATA EXPECTED IN Q3 2025 FRACTYL HEALTH INC - MEDIAN WEIGHT REMAINED STABLE THROUGH 3 MONTHS Source text: ID:nGNX5NhXxz Further company coverage: GUTS.O ((Reuters.Briefs@thomsonreuters.com;))